Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
OGI logo OGI
Upturn stock ratingUpturn stock rating
OGI logo

OrganiGram Holdings Inc (OGI)

Upturn stock ratingUpturn stock rating
$1.29
Last Close (24-hour delay)
Profit since last BUY0.78%
upturn advisory
Consider higher Upturn Star rating
BUY since 28 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/20/2025: OGI (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

4 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $8.8

1 Year Target Price $8.8

Analysts Price Target For last 52 week
$8.8Target price
Low$0.85
Current$1.29
high$2.08

Analysis of Past Performance

Type Stock
Historic Profit -41.63%
Avg. Invested days 27
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/20/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 180.74M USD
Price to earnings Ratio 10.38
1Y Target Price 8.8
Price to earnings Ratio 10.38
1Y Target Price 8.8
Volume (30-day avg) 4
Beta 1.86
52 Weeks Range 0.85 - 2.08
Updated Date 07/1/2025
52 Weeks Range 0.85 - 2.08
Updated Date 07/1/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.13

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 8.7%
Operating Margin (TTM) -11.56%

Management Effectiveness

Return on Assets (TTM) -5.56%
Return on Equity (TTM) -54.53%

Valuation

Trailing PE 10.38
Forward PE 2000
Enterprise Value 176337636
Price to Sales(TTM) 0.93
Enterprise Value 176337636
Price to Sales(TTM) 0.93
Enterprise Value to Revenue 1.25
Enterprise Value to EBITDA 9.27
Shares Outstanding 133884000
Shares Floating 93465712
Shares Outstanding 133884000
Shares Floating 93465712
Percent Insiders 32.41
Percent Institutions 5.6

Analyst Ratings

Rating 2
Target Price 8.8
Buy -
Strong Buy 3
Buy -
Strong Buy 3
Hold 1
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

OrganiGram Holdings Inc

stock logo

Company Overview

overview logo History and Background

OrganiGram Holdings Inc. was founded in 2013 in Moncton, New Brunswick, Canada. It initially focused on producing medical cannabis and has since expanded into recreational cannabis products. It was one of the first licensed producers of cannabis in Canada.

business area logo Core Business Areas

  • Cannabis Cultivation and Production: OrganiGram cultivates and produces a variety of cannabis products, including dried flower, edibles, concentrates, and vape pens.
  • Product Distribution and Sales: The company distributes its products through various channels, including provincial cannabis retailers and online platforms.
  • International Expansion: OrganiGram has been pursuing international expansion, primarily in Europe and Australia, through strategic partnerships and export agreements.

leadership logo Leadership and Structure

The company's CEO is Beena Goldenberg. The organizational structure is based on functional departments with oversight by the executive team and a board of directors.

Top Products and Market Share

overview logo Key Offerings

  • Dried Flower: OrganiGram offers a variety of dried flower strains. Market share data is highly variable and depends on specific provincial markets. Competitors include Canopy Growth, Aurora Cannabis, and Tilray. Difficult to provide marketshare data because it varies by Canadian Province which would require a table.
  • Number of Users or Revenue: N/A
  • Number of Users or Revenue: N/A
  • Vape Pens: OrganiGram's vape pens are popular among consumers. Market share data is highly variable and depends on specific provincial markets. Competitors include Canopy Growth, Aurora Cannabis, and Tilray. Difficult to provide marketshare data because it varies by Canadian Province which would require a table.
  • Edibles: OrganiGram's edibles offerings continue to grow. Market share data is highly variable and depends on specific provincial markets. Competitors include Canopy Growth, Aurora Cannabis, and Tilray. Difficult to provide marketshare data because it varies by Canadian Province which would require a table.
  • Number of Users or Revenue: N/A

Market Dynamics

industry overview logo Industry Overview

The cannabis industry is rapidly evolving with increasing legalization and acceptance. It faces challenges like regulatory complexities and intense competition.

Positioning

OrganiGram positions itself as a producer of high-quality cannabis products with a focus on innovation and international expansion.

Total Addressable Market (TAM)

The global cannabis market is expected to reach hundreds of billions USD in the coming years. OrganiGram is positioned to capture a share of this market through its expansion and product development.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition in certain regions
  • Innovative product development
  • Strategic partnerships
  • Good supply chain management

Weaknesses

  • Limited market share compared to larger competitors
  • Dependence on Canadian market
  • Profitability challenges
  • Negative press/recalls

Opportunities

  • Expansion into new international markets
  • Product diversification (e.g., CBD)
  • Increased legalization of cannabis
  • Partnerships with established brands

Threats

  • Intense competition
  • Regulatory changes
  • Price volatility
  • Supply chain disruptions

Competitors and Market Share

competitor logo Key Competitors

  • TLRY
  • CGC
  • ACB

Competitive Landscape

OrganiGram faces intense competition from larger, more established companies. It differentiates itself through innovative product development and strategic partnerships.

Growth Trajectory and Initiatives

Historical Growth: Growth has been driven by the legalization of cannabis in Canada and international expansion efforts.

Future Projections: Future growth projections depend on market conditions, regulatory developments, and the company's execution of its strategic initiatives. Analyst estimates vary.

Recent Initiatives: Recent initiatives include new product launches and expansion into international markets.

Summary

OrganiGram is a cannabis company with growth potential but faces challenges due to competition and regulatory uncertainty. The company's strengths lie in its innovative products and strategic partnerships. Profitability remains a concern, and market conditions are volatile. Continued focus on international expansion and product diversification is crucial.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Investor Relations
  • Financial News Platforms
  • Industry Reports

Disclaimers:

This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance can change rapidly.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About OrganiGram Holdings Inc

Exchange NASDAQ
Headquaters Toronto, ON, Canada
IPO Launch date 2014-08-27
CEO & Director Ms. Beena G. Goldenberg
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 1150
Full time employees 1150

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company was incorporated in 2010 and is headquartered in Toronto, Canada.